Glezer Eli N. 4
4 · Singular Genomics Systems, Inc. · Filed Sep 17, 2024
Insider Transaction Report
Form 4
Glezer Eli N.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2024-09-15+250→ 154,333 total - Exercise/Conversion
Restricted Stock Units
2024-09-15−250→ 2,500 total→ Common Stock (250 underlying)
Footnotes (4)
- [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]On June 26, 2024, the Issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
- [F3]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F4]The RSUs vest in 16 equal quarterly installments over four years measured from March 15, 2023.